-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Rqa25TiTqq/Q6BlIe5v0tTLcgRBkyaEP1VpydI3RLQFES+NSc3Lc+2no6dbLzLu8 C8oLIRDFh8XLn5lyvoDtxQ== 0001179110-08-016638.txt : 20080911 0001179110-08-016638.hdr.sgml : 20080911 20080911135224 ACCESSION NUMBER: 0001179110-08-016638 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080910 FILED AS OF DATE: 20080911 DATE AS OF CHANGE: 20080911 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES INC CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BERG PAUL CENTRAL INDEX KEY: 0001198229 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 081066918 BUSINESS ADDRESS: STREET 1: STANFORD UNIVERSITY SCHOOL OF MEDICINE STREET 2: BECKMAN CENTER #B062 CITY: STANFORD STATE: CA ZIP: 94305 BUSINESS PHONE: 6507236170 MAIL ADDRESS: STREET 1: STANFORD UNIVERSITY SCHOOL OF MEDICINE STREET 2: #B062 CITY: STANFORD STATE: CA ZIP: 94305 4 1 edgar.xml FORM 4 - X0303 4 2008-09-10 0 0000882095 GILEAD SCIENCES INC GILD 0001198229 BERG PAUL BECKMAN CENTER, RM. B062 STANFORD UNIVERSITY SCHOOL OF MEDICINE STANFORD CA 94305 1 0 0 0 Common Stock 2008-09-10 4 M 0 13450 3.3868 A 36967 D Common Stock 2008-09-10 4 S 0 13450 46.88 D 23517 D Non-Qualified Stock Option (right to buy) 3.3868 2008-09-10 4 M 0 13450 0 D 2010-04-29 Common Stock 13450 27000 D Options vested quarterly over a period of five years beginning July 29, 2000 and were fully vested on April 29, 2005. The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan established by Dr. Berg on October 23, 2007. /s/ Paul Berg 2008-09-10 -----END PRIVACY-ENHANCED MESSAGE-----